ANTI-DIABETIC MEDICINES CONTAINING DPP-4 INHIBITOR (LINAGLIPTIN) OPTIONAL IN COMBINATION WITH OTHER ANTI-DIABETIC MEANS

摘要

The application describes antidiabetic agents that can be used to treat or prevent one or more conditions selected from the group including diabetes mellitus type 1, diabetes mellitus type 2, impaired glucose tolerance and hyperglycemia. In addition, the application describes methods for the prevention or treatment of metabolic disorders and related conditions.